1.Characteristics, management, and predictors of 6-month mortality in very elderly patients admitted for decompensated heart failure.
Prado SALAMANCA-BAUTISTA ; Rocío RUIZ-HUESO ; Irene BRAVO-CANDELA ; Miriam ROMERO-CORREA ; Ana Belkis PORTO-PÉREZ ; Luis Enrique CAJAMARCA-CALVA ; Miguel OTERO-SOLER ; Carlos Jiménez-de JUAN ; Aída GIL-DÍAZ ; Carmen ALEMÁN-LLANSÓ ; Javier ABELLÁN-MARTÍNEZ ; Francesc FORMIGA
Journal of Geriatric Cardiology 2025;22(9):802-811
BACKGROUND:
Patients aged 85 years or older admitted for heart failure (HF) have increased enormously due to improved survival in this disease. However, few studies assess the characteristics, treatments, and prognosis of very elderly patients admitted for acute HF.
METHODS:
This study is a retrospective analysis of the EPICTER registry, that included patients admitted for acute HF in 74 Spanish hospitals. For this analysis, a total of 1887 patients were included and divided into 2 groups: 85 years or older (very elderly, 680 patients) and those under 85 years.
RESULTS:
Compared to patients < 85 years, very elderly patients were more frequently women, had more hypertension and disease cerebrovascular disease, and less presence of chronic obstructive pulmonary disease (COPD), diabetes, and acute myocardial infarction. There were no differences in symptoms, except for delirium, significantly more common in very elderly patients. Management of these patients was more conservative and died more than the younger ones (41% vs. 25%, P < 0.001). The predictor variables of mortality in very elderly patients were the presence of COPD and peripheral arterial disease, delirium, and estimated survival of less than 6 months assessed by the physician in charge of the patient care.
CONCLUSION
Very elderly patients admitted for HF differ from younger ones in comorbidities, management, and symptoms, and have higher mortality. The presence of delirium, peripheral arterial disease, and COPD worsen the prognosis in these patients and can help to adapt the therapeutic effort and place emphasis on adequate symptom control.
2.Analytical Interference of Exemestane with Androstenedione Immunoassays
Marina GIRALT ; Roser FERRER ; Noelia DÍAZ-TROYANO ; Belén VEGA ; Manuel LUQUE-RAMÍREZ ; Sílvia MARTÍNEZ ; Bárbara FERNÁNDEZ ; Irene MARTÍNEZ ; Aleix FABREGAT ; Eulalia URGELL ; Ignacio CARDONA ; Gregori CASALS ; Héctor F. ESCOBAR-MORREALE
Annals of Laboratory Medicine 2025;45(4):410-419
Background:
Exemestane, an aromatase inhibitor commonly used for breast cancer treatment, shares structural similarities with sex steroids analyzed in clinical laboratories. We aimed to investigate the influence of exemestane cross-reactivity in the measurement of sex steroids across various immunoassays.
Methods:
We conducted a multicenter study involving measurements of androstenedione, testosterone, estradiol, progesterone, and 17-hydroxyprogesterone in serum samples from women undergoing exemestane therapy (N = 15; 25 mg/day). Measurements were performed using liquid chromatography-mass spectrometry (LC-MS) and various commercially available chemiluminescence immunoassays, ELISA, and radioimmunoassay. In-vitro cross-reactivity was assessed by adding exemestane and 17-hydroexemestane to serum samples.
Results:
Patients undergoing exemestane therapy had markedly falsely elevated androstenedione results in all immunoassays evaluated (N = 4), which correlated with serum exemestane levels. In-vitro experiments confirmed this interference to be caused by cross-reactivity with exemestane. Additionally, one immunoassay yielded falsely elevated estradiol results in 20% of patients. However, in-vitro experiments did not confirm this to be caused by cross-reactivity with exemestane or 17-hydroexemestane.
Conclusions
Exemestane cross-reacts with androstenedione immunoassays, causing falsely elevated results in treated patients. This analytical interference may raise unnecessary concerns, leading to expensive diagnostic workups.
3.Genotoxic Effects on Gas Station Attendants in South-southeastern México due to Prolonged and Chronic Exposure to Gasoline
Rebeca I. MARTÍNEZ-SALINAS ; Irene SÁNCHEZ-MORENO ; Juan J. Morales LÓPEZ ; Benito Salvatierra IZABA ; Everardo Barba MACÍAS ; Anahí ARMAS-TIZAPANTZI ; Arturo TORRES-DOSAL
Safety and Health at Work 2024;15(2):236-241
Background:
Gasoline, a complex mixture of volatile organic compounds is classified as possibly carcinogenic to humans. Gasoline station attendants, consistently exposed to its hazardous components, may face genotoxic effects. This study aimed to assess the influence of varying work shift durations on DNA damage in gasoline station attendants.
Methods:
Ninety individuals from three locations in southern México were studied. Peripheral blood mononuclear cells (PBMCs) were isolated, and DNA damage was assessed using the comet assay. Demographic, occupational, and lifestyle data were collected. Statistical analyses included t-tests, ANOVA, and Pearson correlation.
Results:
Significant differences in DNA damage parameters were observed between exposed and unexposed groups. The impact of tobacco, alcohol, and exercise on DNA damage was negligible. Extended work shifts (12 and 24 hours) showed heightened DNA damage compared to 8-hour shifts and the unexposed group. A novel finding revealed a modest but significant correlation between DNA damage and job seniority.
Conclusion
The study highlights the intricate relationship between occupational exposure to gasoline components, DNA damage, and work shift lengths. Extended shifts correlate with heightened genotoxic effects, emphasizing the importance of personalized safety measures. The significant correlation between DNA damage and job seniority introduces occupational longevity as a determinant in the genetic health of gasoline station attendants. This discovery has implications for implementing targeted interventions and preventive strategies to safeguard workers' genetic integrity throughout their years of service. The study calls for further exploration of unconsidered factors in understanding the multifactorial nature of DNA damage in this occupational setting.
4.Cerebral Edema in Patients with severe Hemispheric Syndrome: Incidence, Risk Factors, and Outcomes—Data from SITS-ISTR
Irene ESCUDERO-MARTÍNEZ ; Magnus THORÉN ; Peter RINGLEB ; Ana Paiva NUNES ; Manuel CAPPELLARI ; Viiu-Marika RAND ; Piotr SOBOLEWSKI ; Jose EGIDO ; Danilo TONI ; Shih-Yin CHEN ; Nicole TSAO ; Niaz AHMED
Journal of Stroke 2023;25(1):101-110
Background:
and Purpose Cerebral edema (CED) in ischemic stroke can worsen prognosis and about 70% of patients who develop severe CED die if treated conservatively. We aimed to describe incidence, risk factors and outcomes of CED in patients with extensive ischemia.
Methods:
Oservational study based on Safe Implementation of Treatments in Stroke-International Stroke Treatment Registry (2003–2019). Severe hemispheric syndrome (SHS) at baseline and persistent SHS (pSHS) at 24 hours were defined as National Institutes of Health Stroke Score (NIHSS) >15. Outcomes were moderate/severe CED detected by neuroimaging, functional independence (modified Rankin Scale 0–2) and death at 90 days.
Results:
Patients (n=8,560) presented with SHS and developed pSHS at 24 hours; 82.2% received intravenous thrombolysis (IVT), 10.5% IVT+thrombectomy, and 7.3% thrombectomy alone. Median age was 77 and NIHSS 21. Of 7,949 patients with CED data, 3,780 (47.6%) had any CED and 2,297 (28.9%) moderate/severe CED. In the multivariable analysis, age <50 years (relative risk [RR], 1.56), signs of acute infarct (RR, 1.29), hyperdense artery sign (RR, 1.39), blood glucose >128.5 mg/dL (RR, 1.21), and decreased level of consciousness (RR, 1.14) were associated with moderate/severe CED (for all P<0.05). Patients with moderate/severe CED had lower odds to achieve functional Independence (adjusted odds ratio [aOR], 0.35; 95% confidence interval [CI], 0.23 to 0.55) and higher odds of death at 90 days (aOR, 2.54; 95% CI, 2.14 to 3.02).
Conclusions
In patients with extensive ischemia, the most important predictors for moderate/ severe CED were age <50, high blood glucose, signs of acute infarct, hyperdense artery on baseline scans, and decreased level of consciousness. CED was associated with worse functional outcome and a higher risk of death at 3 months.
5.Clinical Outcomes of Mechanical Thrombectomy in Stroke Tandem Lesions According to Intracranial Occlusion Location
Elena ZAPATA-ARRIAZA ; Asier de ALBÓNIGA-CHINDURZA ; Joaquin ORTEGA-QUINTANILLA ; Irene ESCUDERO-MARTÍNEZ ; Francisco MONICHE ; Manuel MEDINA-RODRÍGUEZ ; Blanca PARDO-GALIANA ; Juan Antonio Cabezas RODRÍGUEZ ; Lucía Lebrato HERNÁNDEZ ; Leire AINZ ; Soledad PÉREZ-SÁNCHEZ ; Ana DOMÍNGUEZ-MAYORAL ; Ana BARRAGÁN ; Aurelio CAYUELA ; Joan MONTANER ; Alejandro González GARCÍA
Journal of Stroke 2021;23(1):124-127
6.Sex Differences by Hospital-Level in Performance and Outcomes of Endovascular Treatment for Acute Ischemic Stroke
Soledad PÉREZ-SÁNCHEZ ; Ana BARRAGÁN-PRIETO ; Joaquín ORTEGA-QUINTANILLA ; Ana DOMÍNGUEZ-MAYORAL ; Miguel Ángel GAMERO-GARCÍA ; Elena ZAPATA-ARRIAZA ; Reyes de TORRES-CHACÓN ; Asier de ALBÓNIGA-CHINDURZA ; Montserrat ZAPATA-HIDALGO ; Francisco MONICHE ; Irene ESCUDERO-MARTÍNEZ ; Pablo BAENA ; Juan Antonio CABEZAS ; Juan Miguel OROPESA-RUIZ ; Gema SANZ-FERNÁNDEZ ; Alejandro GONZÁLEZ ; Joan MONTANER
Journal of Stroke 2020;22(2):258-261
7.The Value of Transcranial Doppler Sonography in Hyperperfusion Syndrome after Carotid Artery Stenting: A Nationwide Prospective Study
Francisco MONICHE ; Irene ESCUDERO-MARTÍNEZ ; Fernando MANCHA ; Alejandro TOMASELLO ; Marc RIBÓ ; Fernando DELGADO-ACOSTA ; Juán José OCHOA ; Joaquín GIL ; Rosario GIL ; Montserrat GONZÁLEZ-DELGADO ; Eduardo MURIAS ; Alain LUNA ; Alberto GIL ; Sonia MOSTEIRO ; María Dolores FERNÁNDEZ-COUTO ; Luis Fernández de ALARCÓN ; José M. RAMÍREZ-MORENO ; Joaquín ZAMARRO ; Guillermo PARRILLA ; José L. CANIEGO ; Gustavo ZAPATA-WAINBERG ; Andrés GONZÁLEZ-MANDLY ; José A. de las HERAS ; Luis LÓPEZ-MESONERO ; Joaquín ORTEGA ; Juan F. ARENILLAS ; Ernesto GARCÍA ; Pedro P. ALCÁZAR ; Elena ZAPATA-ARRIAZA ; Asier de ALBÓNIGA-CHINDURZA ; Juan Antonio CABEZAS ; Pilar ALGABA ; Aurelio CAYUELA ; Joan MONTANER ; Alejandro González GARCÍA
Journal of Stroke 2020;22(2):254-257
8.Chest Computed Tomography Findings and Validation of Clinical Criteria of Stroke Associated Pneumonia
Elena ZAPATA-ARRIAZA ; Pilar SERRANO-GOTARREDONA ; Silvia NAVARRO-HERRERO ; Francisco MONICHE ; Blanca PARDO-GALIANA ; Esther PALLISA ; Angela VEGA-SALVATIERRA ; Fernando MANCHA ; Irene ESCUDERO-MARTÍNEZ ; Alejandro BUSTAMANTE ; Joan MONTANER
Journal of Stroke 2019;21(2):217-219
9.Mediterranean Diet and Physical Activity Protect from Silent Brain Infarcts in a Cohort of Patients with Atrial Fibrillation
Irene ESCUDERO-MARTÍNEZ ; Fernando MANCHA ; Angela VEGA-SALVATIERRA ; María Irene AYUSO ; Rafael F OCETE ; Pilar ALGABA ; Antonio LÓPEZ-RUEDA ; Pilar PIÑERO ; Elena FAJARDO ; José Román FERNÁNDEZ-ENGO ; Eva María MARTÍN-SÁNCHEZ ; Alejandro GALVAO-CARMONA ; Elena ZAPATA-ARRIAZA ; Lucía LEBRATO ; Blanca PARDO-GALIANA ; Juan Antonio CABEZAS ; Alejandro GONZÁLEZ ; Francisco MONICHE ; Joan MONTANER
Journal of Stroke 2019;21(3):353-355
No abstract available.
Atrial Fibrillation
;
Brain
;
Cohort Studies
;
Diet, Mediterranean
;
Humans
;
Motor Activity
10.Proposal and Evaluation of a Telerehabilitation Platform Designed for Patients With Partial Rotator Cuff Tears: A Preliminary Study.
Salvador Israel MACÍAS-HERNÁNDEZ ; Diana Sureima VÁSQUEZ-SOTELO ; Marco Vinicio FERRUZCA-NAVARRO ; Susana Hazel BADILLO SÁNCHEZ ; Josefina GUTIÉRREZ-MARTÍNEZ ; Marco Antonio NÚÑEZ-GAONA ; Heriberto Aguirre MENESES ; Oscar Benjamín VELEZ-GUTIÉRREZ ; Irene TAPIA-FERRUSCO ; María de los Ángeles SORIA-BASTIDA ; Roberto CORONADO-ZARCO ; Juan Daniel MORONES-ALBA
Annals of Rehabilitation Medicine 2016;40(4):710-717
OBJECTIVE: To propose and evaluate the effectiveness of a telerehabilitation platform designed for patients with rotator cuff (RC) tears. METHODS: During the first study phase, a virtual service platform that included information on RC tear pathology, joint care, and a series of instructions regarding therapeutic exercise was designed and created. Subsequently, in the clinical phase, a quasi-experimental study was performed. The platform was tested on patients and evaluated at baseline and at 1, 2, 3, and 6 months with respect to their pain levels and functionality on the Constant-Murley (CM) scale. RESULTS: Eleven patients were included, 5 women and 6 men, with a median age of 55 years (range, 42–68 years). Pain diminished from a baseline value of 64 mm (range, 40–80 mm) to 16 mm (range, 0–30 mm) at 6 months (p<0.001). Points on the CM scale rose from a baseline value of 54 points (range, 51–66 points) to 85 points (range, 70–100 points) at 6 months (p=0.001). Functionality in daily living and work activities, movement, and strength exhibited significant changes at 6 months (p<0.05). CONCLUSION: Significant changes were observed in pain and functionality in this group of participants who used a telerehabilitation platform. To the best of our knowledge, this is the first study that included a specific program for RC tears.
Female
;
Humans
;
Joints
;
Male
;
Non-Randomized Controlled Trials as Topic
;
Pathology
;
Rehabilitation
;
Remote Consultation
;
Rotator Cuff*
;
Shoulder
;
Tears*
;
Telemedicine
;
Telerehabilitation*

Result Analysis
Print
Save
E-mail